This microlearning activity is designed to help pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in understanding advances in I-O biomarkers, in particular, PD-L1, MSI, and TMB. This activity focuses on evaluation methods and clinical significance of each of these biomarkers.
Course topics include:
- Evaluation methods and the clinical significance of PD-L1
- Evaluation methods and the clinical significance of MSI
- Evaluation methods and the clinical significance of TMB
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Learning Objectives
Upon completion of this activity, you will be able to:
- Identify the evaluation methods and the clinical significance of PD-L1 as a predictive marker in immuno-oncology
- Define MSI, its evaluation methods, and its clinical significance as a predictive marker in immuno-oncology
- Define TMB, its evaluation methods, and its clinical significance as a predictive marker in immuno-oncology
Faculty
Yin P. Hung, M.D., Ph.D.
Medical Director, Histology and Ancillary Diagnostic Laboratories
Associate Professor of Pathology, Harvard Medical School
Department of Pathology, Massachusetts General Hospital
Boston, Massachusetts
Faculty Disclosures
Yin P. Hung has no financial relationships to disclose.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of .25 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must participate in the course. CME certificates will be provided online.
Commercial Support
This activity is supported by an independent educational grant from Bristol Myers Squibb.